SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-246045
Filing Date
2022-09-16
Accepted
2022-09-16 07:50:48
Documents
7
Effectiveness Date
2022-09-16

Document Format Files

Seq Description Document Type Size
1 S-8 d259216ds8.htm S-8 51805
2 EX-5.1 d259216dex51.htm EX-5.1 6790
3 EX-23.2 d259216dex232.htm EX-23.2 1533
4 EX-FILING FEES d259216dexfilingfees.htm EX-FILING FEES 19886
5 GRAPHIC g259216dsp.jpg GRAPHIC 11470
6 GRAPHIC g259216dsp11.jpg GRAPHIC 2453
7 GRAPHIC g259216g0915082624044.jpg GRAPHIC 1649
  Complete submission text file 0001193125-22-246045.txt   102984
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-267451 | Film No.: 221246986
SIC: 2834 Pharmaceutical Preparations